Furthermore, subgroup analyses indicated a statistically significant reduction in IL-6 levels among studies involving participants with obesity who underwent treatment for durations longer than 12 wk and when synbiotics were used as an intervention (Table 2). Here, IL6 is linked to obesity disorder.